Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (20742)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 21, 2016 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mikolasevic I, Milic S, Turk Wensveen T, Grgic I, Jakopcic I, Stimac D, Wensveen F, Orlic L. Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol 2016; 22(43): 9488-9505 [PMID: 27920470 DOI: 10.3748/wjg.v22.i43.9488] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i43/9488.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Na Li, Ying Liu, Shujun Yu, Bin Hu, Hui Zhao. Composite BMI and Waist-to-Height Ratio Index for Risk Assessment of Non-alcoholic Fatty Liver Disease in Adult Populations. Hepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.103607
|
| 3 |
Friedrich Horn, Till Ittermann, Marie-Luise Kromrey, Danilo Seppelt, Henry Völzke, Jens-Peter Kühn, Felix Schön. Exploring factors associated with non-alcoholic fatty liver disease using longitudinal MRI. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03300-0
|
| 4 |
Shasha Zhu, Huimin Zhang, Li Bai. NKT cells in liver diseases. Frontiers of Medicine 2018; 12(3): 249 doi: 10.1007/s11684-018-0622-3
|
| 5 |
A V Gordienko, I I Zhirkov, D Yu Serdyukov. Lipid status and vascular bloodstream of servicemen with initial liver fibrosis. Bulletin of the Russian Military Medical Academy 2018; 20(1): 98 doi: 10.17816/brmma12232
|
| 6 |
Ivana Mikolasevic, Viktor Domislovic, Irena Krznaric-Zrnic, Zeljko Krznaric, Lucija Virovic-Jukic, Sanja Stojsavljevic, Ivica Grgurevic, Sandra Milic, Ivan Vukoja, Petra Puz, Merica Aralica, Goran Hauser. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. Medicina 2022; 58(2): 252 doi: 10.3390/medicina58020252
|
| 7 |
Michael H. Le, Yee Hui Yeo, Linda Henry, Mindie H. Nguyen. Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016. Hepatology Communications 2019; 3(10): 1334 doi: 10.1002/hep4.1408
|
| 8 |
Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questions. Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
|
| 9 |
Ivana Mikolasevic, Goran Hauser, Maja Mijic, Viktor Domislovic, Delfa Radic-Kristo, Zeljko Krznaric, Melanija Razov-Radas, Tajana Pavic, Marija Matasin, Tajana Filipec Kanizaj, Kevork Peltekian. Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6657047
|
| 10 |
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
|
| 11 |
Letao Fan, Aslihan Gokaltun, Sarah Maggipinto, Yoshinori Kitagawa, Jeevendra Martyn, Heidi Yeh, Basak E. Uygun, Martin L. Yarmush, O. Berk Usta. Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(2): 243 doi: 10.1016/j.jcmgh.2023.04.003
|
| 12 |
Felix M. Wensveen, Marko Šestan, Tamara Turk Wensveen, Bojan Polić. ‘Beauty and the beast’ in infection: How immune–endocrine interactions regulate systemic metabolism in the context of infection. European Journal of Immunology 2019; 49(7): 982 doi: 10.1002/eji.201847895
|
| 13 |
I. Mikolasevic, D. Rahelic, T. Turk-Wensween, A. Ruzic, V. Domislovic, G. Hauser, T. Matic, D. Radic-Kristo, Z. Krznaric, M. Radic, T. Filipec Kanizaj, M. Martinovic, H. Jerkic, M. Medjimurec, G. Targher. Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study. Diabetes Research and Clinical Practice 2021; 177: 108884 doi: 10.1016/j.diabres.2021.108884
|
| 14 |
Jannis Kountouras, Stergios A. Polyzos, Michael Doulberis, Christos Zeglinas, Fotini Artemaki, Elizabeth Vardaka, Georgia Deretzi, Evaggelia Giartza-Taxidou, Dimitri Tzivras, Efthymia Vlachaki, Evangelos Kazakos, Panagiotis Katsinelos, Christos S. Mantzoros. Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. Metabolism 2018; 87: 18 doi: 10.1016/j.metabol.2018.06.008
|
| 15 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 16 |
Ahmed Hashim, Ahmed Maraey, Ahmed Elzanaty, Magdi Zordok, Hadeer Elsharnoby, Mahmoud Khalil, Omar Al Wahadneh, Helmy Siragy. Nonalcoholic Fatty Liver Disease Predicts Acute Kidney Injury Readmission in Heart Failure Hospitalizations: A Nationwide Analysis. Current Problems in Cardiology 2023; 48(10): 101816 doi: 10.1016/j.cpcardiol.2023.101816
|
| 17 |
Tiziana Ciarambino, Pietro Crispino, Gloria Guarisco, Mauro Giordano. Gender Differences in Insulin Resistance: New Knowledge and Perspectives. Current Issues in Molecular Biology 2023; 45(10): 7845 doi: 10.3390/cimb45100496
|
| 18 |
Esra IRMAK, Rukiye BOZBULUT. D Vitamini Eksikliği ve Obezite İlişkisi. Avrasya Sağlık Bilimleri Dergisi 2022; 6(1): 50 doi: 10.53493/avrasyasbd.1152750
|
| 19 |
Hong‐Yi Lin, Pooi Ling Loi, Jeanette Ng, Liang Shen, Wei‐Quan Teo, Amber Chung, Prema Raj, Jason Pik‐Eu Chang. MELD3.0 is superior to MELDNa and MELD for prediction of mortality in patients with cirrhosis: An external validation in a multi‐ethnic population. JGH Open 2024; 8(6) doi: 10.1002/jgh3.13098
|
| 20 |
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
|
| 21 |
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1): e34934 doi: 10.1097/MD.0000000000034934
|
| 22 |
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. Annals of Hepatology 2019; 18(5): 693 doi: 10.1016/j.aohep.2019.04.012
|
| 23 |
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. Pharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
|
| 24 |
Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari, Gholamreza Askari. Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Clinical Practice 2021; 42: 101281 doi: 10.1016/j.ctcp.2020.101281
|
| 25 |
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
|
| 26 |
A. P. Gonchar, V. A. Gombolevskij, A. B. Elizarov, N. S. Kulberg, M. M. Suleymanova, T. I. Alekseeva, D. A. Chernyshev, M. Yu. Titov, T. A. Levina, V. Yu. Bosin, S. P. Morozov. Possibilities of liver density estimation according to noncontrast computed tomography. Journal of radiology and nuclear medicine 2020; 101(1): 58 doi: 10.20862/0042-4676-2020-101-1-58-66
|
| 27 |
Karlo Mladenić, Maja Lenartić, Sonja Marinović, Bojan Polić, Felix M. Wensveen. The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis. European Journal of Immunology 2024; 54(4) doi: 10.1002/eji.202149641
|
| 28 |
Ivana Mikolasevic, Sanja Stojsavljevic, Filip Blazic, Maja Mijic, Delfa Radic-Kristo, Toni Juric, Nadija Skenderevic, Mia Klapan, Andjela Lukic, Tajana Filipec Kanizaj. Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?. World Journal of Transplantation 2021; 11(3): 37-53 doi: 10.5500/wjt.v11.i3.37
|
| 29 |
Rohitash Jamwal, Suzanne M. de la Monte, Ken Ogasawara, Sravani Adusumalli, Benjamin B. Barlock, Fatemeh Akhlaghi. Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver. Molecular Pharmaceutics 2018; 15(7): 2621 doi: 10.1021/acs.molpharmaceut.8b00159
|
| 30 |
Mehmet Sayiner, Tamoore Arshad, Pegah Golabi, James Paik, Freba Farhat, Zobair M. Younossi. Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population. Hepatology International 2020; 14(4): 556 doi: 10.1007/s12072-020-10038-w
|
| 31 |
Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A. Fernández-Rojo, Marta G. Novelle. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. International Journal of Molecular Sciences 2020; 21(24): 9368 doi: 10.3390/ijms21249368
|
| 32 |
Jie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, Yu Yi Chan, Ansel Shao Pin Tang, Margaret Teng, Darren Jun Hao Tan, Wen Hui Lim, Jingxuan Quek, Jieling Xiao, Yip Han Chin, Roger Foo, Mark Chan, Weiqin Lin, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah, Arun Sanyal, Nicholas W. S. Chew. Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis. Hepatology International 2022; 16(2): 269 doi: 10.1007/s12072-022-10319-6
|
| 33 |
Simona Cernea, Danusia Onișor, Andrada Larisa Roiban, Theodora Benedek, Nora Rat. Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes. World Journal of Cardiology 2024; 16(10): 580-594 doi: 10.4330/wjc.v16.i10.580
|
| 34 |
Hengxian Qu, Longfei Zhang, Xiaoxiao Liu, Yang Liu, Kaidong Mao, Guiqi Shen, Yunchao Wa, Dawei Chen, Yujun Huang, Xia Chen, Ruixia Gu. Modulatory Effect of Limosilactobacillus fermentum grx08 on the Anti-Oxidative Stress Capacity of Liver, Heart, and Kidney in High-Fat Diet Rats. Fermentation 2022; 8(11): 594 doi: 10.3390/fermentation8110594
|
| 35 |
Luigi Barrea, Carolina Di Somma, Giovanna Muscogiuri, Giovanni Tarantino, Gian Carlo Tenore, Francesco Orio, Annamaria Colao, Silvia Savastano. Nutrition, inflammation and liver-spleen axis. Critical Reviews in Food Science and Nutrition 2018; 58(18): 3141 doi: 10.1080/10408398.2017.1353479
|
| 36 |
Ivana Mikolasevic, Goran Poropat, Tajana Filipec Kanizaj, Nadija Skenderevic, Marko Zelic, Marija Matasin, Luka Vranic, Andrea Kresovic, Goran Hauser, Geoffrey Williams. Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6670065
|
| 37 |
Linxin Xu, Ting Li, Jianhong Yin, Gang Lin, Yali Xu, Yi Ren, Yan Wang, Jing Yang, Liming Chen. Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. PeerJ 2019; 7: e7563 doi: 10.7717/peerj.7563
|
| 38 |
Ivana Mikolasevic, Andela Lukic, Toni Juric, Mia Klapan, Petra Madzar, Nikola Krolo, Doris Kolovrat, Ivanka Jurica, Iva Kedmenec, Domagoj Kihas, Doris Ilovaca, Ivan Erstic, Vanda Haralovic, Danijel Cavlina, Ema Dejhalla, Danijela Erdeljac, Benjamin Vukalovic, Nadija Skenderevic, Sandra Milic. Non-alcoholic fatty liver disease and transient elastography. Exploration of Medicine 2020; 1(4): 205 doi: 10.37349/emed.2020.00014
|
| 39 |
Ivana Mikolasevic, Bozena Delija, Ana Mijic, Tajana Stevanovic, Nadija Skenderevic, Ivan Sosa, Irena Krznaric‐Zrnic, Maja Abram, Zeljko Krznaric, Viktor Domislovic, Tajana Filipec Kanizaj, Delfa Radic‐Kristo, Aleksandar Cubranic, Aron Grubesic, Radislav Nakov, Ivana Skrobonja, Davor Stimac, Goran Hauser. Small intestinal bacterial overgrowth and non‐alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. International Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13947
|
| 40 |
Fatma Al Ghaithi, Mostafa I. Waly, Yahya Al-Farsi, Zainab Al Mukhaini, Ruqaiya Al Balushi, Ahmed Almashrafi. Biochemical and nutritional determinants of non-alcoholic fatty liver disease in Omani adult patients: a case-control study. International Journal of Nutrition, Pharmacology, Neurological Diseases 2024; 14(4): 407 doi: 10.4103/ijnpnd.ijnpnd_57_24
|
| 41 |
M. Raja Gopal Reddy, S. Mullapudi Venkata, U.K. Putcha, S.M. Jeyakumar. Vitamin A deficiency induces endoplasmic reticulum stress and apoptosis in pancreatic islet cells: Implications of stearoyl-CoA desaturase 1-mediated oleic acid synthesis. Experimental Cell Research 2018; 364(1): 104 doi: 10.1016/j.yexcr.2018.01.040
|
| 42 |
I. Mikolasevic, V. Domislovic, A. Ruzic, G. Hauser, D. Rahelic, S. Klobucar-Majanovic, Z. Krznaric, R. Dobrila-Dintinjana, I. Grgurevic, N. Skenderevic, A. Lukic, G. Targher. Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 2022; 36(8): 108226 doi: 10.1016/j.jdiacomp.2022.108226
|
| 43 |
Any Carolina Cardoso Guimarães Vasconcelos, Daniel Fernando Pereira Vasconcelos, Felipe Rodolfo Pereira da Silva, Luiz Felipe de Carvalho França, Even Herlany Pereira Alves, David Di Lenardo, Larissa dos Santos Pessoa, Pedro Duarte Novaes, André Luiz dos Reis Barbosa, Arya Mani, Flávia Sammartino Mariano, Jand‐Venes Rolim Medeiros, Aldeídia Pereira de Oliveira. Periodontitis causes abnormalities in the liver of rats. Journal of Periodontology 2019; 90(3): 295 doi: 10.1002/JPER.18-0226
|
| 44 |
Derek Ugwendum, Mouhanad Mohamed, Yazan A Al-Ajlouni, Nso Nso, Basile Njei. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024; doi: 10.7759/cureus.62441
|
| 45 |
Ping Wang, Hua Qiang, Yan Song, Ying Dang, Hui Luan, Lifei Cao, Qing Cui, Gang Tian. Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. Cardiology 2019; 144(3-4): 90 doi: 10.1159/000502111
|
| 46 |
I. Mikolasevic, V. Lukenda Zanko, I. Jakopcic, V. Domislovic, A. Mijic, T. Stevanovic, B. Delija, T. Bokun, P. Dinjar Kujundzic, A. Ostojic, T. Filipec Kanizaj, I. Grgurevic, Z. Krznaric, D. Stimac, G. Targher. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. Journal of Diabetes and its Complications 2020; 34(3): 107512 doi: 10.1016/j.jdiacomp.2019.107512
|
| 47 |
Yuri Cho, Soo‐Kyung Lim, Sae Kyung Joo, Dong‐Hyong Jeong, Jung Ho Kim, Jeong Mo Bae, Jeong Hwan Park, Mee Soo Chang, Dong Hyeon Lee, Yong Jin Jung, Byeong Gwan Kim, Donghee Kim, Kook Lae Lee, Won Kim. Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm. Liver International 2019; 39(9): 1722 doi: 10.1111/liv.14163
|
| 48 |
Brindhadevi Kathirvel, Mohamad S. AlSalhi, Hai-Anh Ha, Thai-Hang Nguyen-Thi. Anti-inflammatory, anti-diabetic, and biocompatibility properties of aqueous extract of Tamarindus indica L. fruit coat analyses by in-vitro and in-vivo approaches. Environmental Research 2024; 251: 118702 doi: 10.1016/j.envres.2024.118702
|
| 49 |
Naheed Bano, Imran Imran. Carotenoids: Structure and Function in the Human Body. 2021; : 585 doi: 10.1007/978-3-030-46459-2_18
|
| 50 |
Elena S. George, Stuart K. Roberts, Amanda J. Nicoll, Anjana Reddy, Tonya Paris, Catherine Itsiopoulos, Audrey C. Tierney. Non‐alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence. Internal Medicine Journal 2018; 48(11): 1369 doi: 10.1111/imj.13973
|
| 51 |
Dan Jia, Zi Wen Li, Xinxin Zhou, Ying Gao, Yifan Feng, Min Ma, Zhengzhi Wu, Weimin Li. A novel berberine‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats. Clinical and Experimental Pharmacology and Physiology 2019; 46(6): 533 doi: 10.1111/1440-1681.13085
|
| 52 |
Sara Della Torre. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572490
|
| 53 |
Binbin Pan, Xin Wan, Mengqing Ma, Changchun Cao. Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study. Kidney and Blood Pressure Research 2020; 45(1): 61 doi: 10.1159/000504172
|
| 54 |
Ivica Grgurevic, Kristian Podrug, Ivana Mikolasevic, Michal Kukla, Anita Madir, Emmanuel A. Tsochatzis. Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/9181368
|
| 55 |
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?. World Journal of Gastroenterology 2018; 24(14): 1491-1506 doi: 10.3748/wjg.v24.i14.1491
|
| 56 |
Xiaoxiao Ge, Tao Sun, Yanmei Zhang, Yongqing Li, Peng Gao, Dantong Zhang, Bingyang Zhang, Peijun Wang, Wanshan Ma, Sumei Lu. The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease. Nutrition & Metabolism 2022; 19(1) doi: 10.1186/s12986-021-00634-4
|
| 57 |
Shayan Eghdami, Fatemeh Afrashteh, Asie Shojaii, Maryam Abolhasani, Manijeh Motevalian. The therapeutic effect of alcoholic extract of Fumaria parviflora on high-fat diet-induced nonalcoholic fatty liver in rats; an animal experiment. Annals of Medicine & Surgery 2024; doi: 10.1097/MS9.0000000000001890
|
| 58 |
Jin Yoo, In-Jin Cho, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, You-Cheol Hwang. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation. Toxicology and Applied Pharmacology 2018; 360: 18 doi: 10.1016/j.taap.2018.09.032
|
| 59 |
Javier A Tamargo, Kenneth E Sherman, Adriana Campa, Sabrina S Martinez, Tan Li, Jacqueline Hernandez, Colby Teeman, Raul N Mandler, Jun Chen, Richard L Ehman, Marianna K Baum. Food insecurity is associated with magnetic resonance–determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV. The American Journal of Clinical Nutrition 2021; 113(3): 593 doi: 10.1093/ajcn/nqaa362
|
| 60 |
Milton Packer. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease. The American Journal of Medicine 2020; 133(2): 170 doi: 10.1016/j.amjmed.2019.09.002
|
| 61 |
Xi-Chen Zhao, Bo Ju, Na Wei, Jian Ding, Fan-Jun Meng, Hong-Guo Zhao. Severe hyperlipemia-induced pseudoerythrocytosis - Implication for misdiagnosis and blood transfusion: A case report and literature review. World Journal of Clinical Cases 2020; 8(19): 4595-4602 doi: 10.12998/wjcc.v8.i19.4595
|
| 62 |
Sechang Oh, Takehiko Tsujimoto, Bokun Kim, Fumihiko Uchida, Hideo Suzuki, Seiichiro Iizumi, Tomonori Isobe, Takeji Sakae, Kiyoji Tanaka, Junichi Shoda. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD. JHEP Reports 2021; 3(3): 100253 doi: 10.1016/j.jhepr.2021.100253
|
| 63 |
Elizabeth L. Godfrey, Tahir H. Malik, Jennifer C. Lai, Ayse L. Mindikoglu, N. Thao N. Galván, Ronald T. Cotton, Christine A. O’Mahony, John A. Goss, Abbas Rana. The decreasing predictive power of MELD in an era of changing etiology of liver disease. American Journal of Transplantation 2019; 19(12): 3299 doi: 10.1111/ajt.15559
|
| 64 |
Vitor Ferreira, Cintia Folgueira, María García-Altares, Maria Guillén, Mónica Ruíz-Rosario, Giada DiNunzio, Irma Garcia-Martinez, Rosa Alen, Christoph Bookmeyer, John G. Jones, Juan C. Cigudosa, Pilar López-Larrubia, Xavier Correig-Blanchar, Roger J. Davis, Guadalupe Sabio, Patricia Rada, Ángela M. Valverde. Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition. Redox Biology 2023; 63: 102741 doi: 10.1016/j.redox.2023.102741
|
| 65 |
Muhammad Sohaib Asghar, Maira Hassan, Uzma Rasheed, Syed Jawad Haider Kazmi, Noman A Khan, Faran Khalid, Ayesha Anum, Saira Anwar. Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease. Cureus 2020; doi: 10.7759/cureus.11146
|
| 66 |
Maria Azparren-Angulo, Felix Royo, Esperanza Gonzalez, Marc Liebana, Bruno Brotons, Jesús Berganza, Felipe Goñi-de-Cerio, Nicoló Manicardi, Laia Abad-Jordà, Jordi Gracia-Sancho, Juan M. Falcon-Perez. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacology & Therapeutics 2021; 218: 107683 doi: 10.1016/j.pharmthera.2020.107683
|
| 67 |
Jiawang Zou, Hailan Xiong, Huimin Zhang, Chong Hu, Song Lu, Yang Zou. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02099-y
|
| 68 |
Yu-Hua Chu, Lee Wang, Pei-Chieh Ko, Shou-Jen Lan, Yung-Po Liaw. The risk of cirrhosis in non-alcohol drinkers is greater in female than male betel nut chewers. Oncotarget 2018; 9(9): 8731 doi: 10.18632/oncotarget.23885
|
| 69 |
Mohammad Hassan Sohouli, Somaye Fatahi, Elma Izze da Silva Magalhães, Bianca Rodrigues de Oliveira, Pejman Rohani, Neda Ezoddin, Mehdi Mehdinezhad Roshan, Azita Hekmatdoost. Adherence to a Paleolithic Diet in Combination With Lifestyle Factors Reduces the Risk for the Presence of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.934845
|
| 70 |
Luka Vranić, Ivana Mikolašević, Sandra Milić. Vitamin D Deficiency: Consequence or Cause of Obesity?. Medicina 2019; 55(9): 541 doi: 10.3390/medicina55090541
|
| 71 |
S.M. Clifford, D.J. Murphy. Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link?. Journal of Nuclear Cardiology 2021; 28(2): 621 doi: 10.1007/s12350-019-01783-z
|
| 72 |
Mehrnoosh Shanaki, Nariman Moradi, Solaleh Emamgholipour, Reza Fadaei, Hossein Poustchi. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S467 doi: 10.1016/j.dsx.2017.03.037
|
| 73 |
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang, Kamal D. Moudgil. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/5378961
|
| 74 |
Laura Inés Elvira-Torales, Javier García-Alonso, María Jesús Periago-Castón. Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review. Antioxidants 2019; 8(7): 229 doi: 10.3390/antiox8070229
|
| 75 |
Ivana Mikolasevic, Viktor Domislovic, Mia Klapan, Toni Juric, Andjela Lukic, Irena Krznaric-Zrnic, Dora Fuckar-Cupic, Davor Stimac, Tajana Filipec Kanizaj, Zeljko Krznaric, Delfa Radic-Kristo, Sandra Milic, Marko Martinovic, Aron Grubesic, Ivica Grgurevic. Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2021; 47(3): 428 doi: 10.1016/j.ultrasmedbio.2020.11.015
|
| 76 |
Ludovico Abenavoli, Marta Greco, Natasa Milic, Francesca Accattato, Daniela Foti, Elio Gulletta, Francesco Luzza. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients 2017; 9(8): 870 doi: 10.3390/nu9080870
|
| 77 |
Umar Hayat, Ali A. Siddiqui, Muhammad L. Farhan, Ahmed Haris, Nasir Hameed. Genome Editing in Cardiovascular and Metabolic Diseases. Advances in Experimental Medicine and Biology 2023; 1396: 191 doi: 10.1007/978-981-19-5642-3_13
|
| 78 |
Lindsay Van den Bossche, Vivien A. C. Schoonenberg, Iwan A. Burgener, Louis C. Penning, Ingrid M. Schrall, Hedwig S. Kruitwagen, Monique E. van Wolferen, Guy C. M. Grinwis, Anne Kummeling, Jan Rothuizen, Jeroen F. van Velzen, Nikolas Stathonikos, Martijn R. Molenaar, Bernd J. Helms, Jos F. H. M. Brouwers, Bart Spee, Frank G. van Steenbeek, Monika Oberer. Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts. PLOS ONE 2017; 12(10): e0186491 doi: 10.1371/journal.pone.0186491
|
| 79 |
Zhao-Chun Chi. Research status and progress of metabolic associated fatty liver disease. World Chinese Journal of Digestology 2022; 30(1): 1 doi: 10.11569/wcjd.v30.i1.1
|
| 80 |
Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar. Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase. Molecular and Cellular Endocrinology 2025; 595: 112404 doi: 10.1016/j.mce.2024.112404
|
| 81 |
Xiaoyu Wang, Yong Han, Yufei Liu, Haofei Hu. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02500-w
|
| 82 |
Alessandra Ferramosca, Mariangela Di Giacomo, Vincenzo Zara. Antioxidant dietary approach in treatment of fatty liver: New insights and updates. World Journal of Gastroenterology 2017; 23(23): 4146-4157 doi: 10.3748/wjg.v23.i23.4146
|
| 83 |
Yusuf Aksu, Ali Ugur Uslu, Gulten Tarhan, Şaban Tiryaki. Renal Artery Resistive Index and Estimated Glomerular Filtration Rate in Patients with Non-alcoholic Fatty Liver Disease. Current Medical Imaging Reviews 2022; 18(12): 1318 doi: 10.2174/1573405618666220516123519
|
| 84 |
D. К. Zakharova, N. V. Nudnov, М. R. Kodenko, R. V. Reshetnikov, А. P. Gonchar. Hepatic Steatosis Detection by Computer Vision During Chest Low-Dose Computed Tomography in Lung Cancer Screening Program. Journal of radiology and nuclear medicine 2023; 104(1): 40 doi: 10.20862/0042-4676-2023-104-1-40-46
|
| 85 |
Nicholas W. S. Chew, Cheng Han Ng, Mark Dhinesh Muthiah, Arun J. Sanyal. Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. Current Atherosclerosis Reports 2022; 24(7): 515 doi: 10.1007/s11883-022-01027-5
|
| 86 |
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Ji Hye Kim, Byung-gyu Kim, Bokyung Lee, Sung Mun Bae, Eun-Kyung Kim. AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling. Foods 2021; 10(9): 1973 doi: 10.3390/foods10091973
|
| 87 |
Tian Jiang, Xia Chen, Chenmei Xia, Huamin Liu, Haifan Yan, Guoping Wang, Zhongbiao Wu. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease in North Chinese: a cross-sectional study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41371-2
|
| 88 |
Guilherme Moura Cunha, Cristiane A. Villela-Nogueira, Anke Bergman, Flavia Paiva Proença Lobo Lopes. Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD. Abdominal Radiology 2018; 43(9): 2340 doi: 10.1007/s00261-018-1504-5
|
| 89 |
Muhammad Naeem, Robin Bülow, Sabine Schipf, Nicole Werner, Marcus Dörr, Markus M. Lerch, Jens-Peter Kühn, Wolfgang Rathmann, Matthias Nauck, Marcello Ricardo Paulista Markus, Till Ittermann, Henry Völzke. Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92681-3
|
| 90 |
Ferah Armutcu, Oguz Aslan Ozen. Inter-organ Crosstalk and the Effect on the Aging Process in Obesity. Current Aging Science 2023; 16(2): 97 doi: 10.2174/1874609816666230223110458
|
| 91 |
Zhiyuan Chen, Yaling Liu, Li Yang, Peng Liu, Yu Zhang, Xiangyang Wang. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunology Letters 2020; 222: 40 doi: 10.1016/j.imlet.2020.03.003
|
| 92 |
Any Carolina Cardoso Guimarães Vasconcelos, Daniel Fernando Pereira Vasconcelos, Felipe Rodolfo Pereira da Silva, Luiz Felipe de Carvalho França, Even Herlany Pereira Alves, David Di Lenardo, Larissa dos Santos Pessoa, Hélio Mateus Silva Nascimento, André dos Santos Carvalho, Francisca Beatriz de Melo Sousa, André Luiz dos Reis Barbosa, Jand‐Venes Rolim Medeiros, Pedro Duarte Novaes, Flávia Sammartino Mariano, Bruno dos Santos Lima, Adriano Antunes de Souza Araujo, Lucindo José Quintans Júnior, Aldeídia Pereira de Oliveira. Alpha‐terpineol complexed with beta‐cyclodextrin reduces damages caused by periodontitis in rats. Journal of Periodontal Research 2020; 55(6): 877 doi: 10.1111/jre.12780
|
| 93 |
Daria L Varganova, Chavdar S Pavlov, Giovanni Casazza, Dimitrinka Nikolova, Christian Gluud. Essential phospholipids for people with non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013301
|
| 94 |
A. I. Ershova, D. O. Al Rashi, A. A. Ivanova, Yu. O. Aksenova, A. N. Meshkov. Secondary hyperlipidemias: etiology and pathogenesis. Russian Journal of Cardiology 2019; (5): 74 doi: 10.15829/1560-4071-2019-5-74-81
|
| 95 |
J. Weyler, A. Verrijken, T. Hornemann, L. Vonghia, E. Dirinck, A. von Eckardstein, T. Vanwolleghem, P. Michielsen, F. Peiffer, A. Driessen, G. Hubens, B. Staels, S. Francque, L. Van Gaal. Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. Acta Diabetologica 2021; 58(3): 319 doi: 10.1007/s00592-020-01612-7
|
| 96 |
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6563
|
| 97 |
Sima Golmohammadi, Marjan Tavasoli, Nadia Asadi. <p>Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver</p>. Clinical and Experimental Gastroenterology 2020; : 299 doi: 10.2147/CEG.S253619
|
| 98 |
Naga Venkata K. Pothineni, Yogita Rochlani, Swathi Subramany, Swathi Kovelamudi, Jawahar L. Mehta. Hepatic Interactions in Atherosclerotic Heart Disease. The American Journal of the Medical Sciences 2022; 363(2): 104 doi: 10.1016/j.amjms.2021.07.011
|
| 99 |
Amreen Dinani, Arun Sanyal. Nonalcoholic fatty liver disease: implications for cardiovascular risk. Cardiovascular Endocrinology 2017; 6(2): 62 doi: 10.1097/XCE.0000000000000126
|
| 100 |
Nighat Gull, Fareeha Arshad, Gowhar A. Naikoo, Israr Ul Hassan, Mona Zamani Pedram, Arif Ahmad, Alaa A. A. Aljabali, Vijay Mishra, Saurabh Satija, Nitin Charbe, Poonam Negi, Rohit Goyal, Ángel Serrano-Aroca, Mazhar S. Al Zoubi, Mohamed El-Tanani, Murtaza M. Tambuwala. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2023; 54(2): 368 doi: 10.1007/s12029-022-00809-z
|
| 101 |
Clara Meda, Arianna Dolce, Elisabetta Vegeto, Adriana Maggi, Sara Della Torre. ERα-Dependent Regulation of Adropin Predicts Sex Differences in Liver Homeostasis during High-Fat Diet. Nutrients 2022; 14(16): 3262 doi: 10.3390/nu14163262
|
| 102 |
Mingzhe Zhu, Shijun Hao, Tao Liu, Lili Yang, Peiyong Zheng, Li Zhang, Guang Ji. Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq. Oncotarget 2017; 8(47): 82621 doi: 10.18632/oncotarget.19734
|
| 103 |
Luka Vranić, Anja Radovan, Goran Poropat, Ivana Mikolašević, Sandra Milić. Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time. Medicina 2021; 57(10): 1057 doi: 10.3390/medicina57101057
|
| 104 |
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
|
| 105 |
Hammad Ismail, Zaryab Mubashar, Hajra Khan, Zeenat Naveed, Erum Dilshad, Muhammad Zeeshan Bhatti, Sadaf Anwaar, Samreen Saleem, Sabba Mehmood, Abdur Rahman, Umer Rashid, Dalia Fouad, Michel De Waard, Gaber El-Saber Batiha. Effects of a High Trans Fatty Acid Diet on Kidney-, Liver-, and Heart-Associated Diseases in a Rabbit Model. Metabolites 2024; 14(8): 442 doi: 10.3390/metabo14080442
|
| 106 |
清莲 宋. Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2019; 9(09): 1073 doi: 10.12677/ACM.2019.99165
|
| 107 |
Jinxiu Wang, Tala Shi, Lanlan Xu, Yanuo Li, Wei Mi, Chunyang Wang, Peng Lu, Lingyun Li, Ziyue Liu, Zhiyong Hu. Correlation between hyperlipidemia and serum vitamin D levels in an adult Chinese cohort. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1302260
|
| 108 |
S. V. Okovity, K. L. Raikhelson, A. V. Volnukhin, D. A. Kudlai. Hepatoprotective properties of glycyrrhizic acid. Experimental and Clinical Gastroenterology 2020; (12): 96 doi: 10.31146/1682-8658-ecg-184-12-96-108
|
| 109 |
Francisco Pino-de la Fuente, Laura Quezada, Carlos Sepúlveda, Matías Monsalves-Alvarez, Juan M. Rodríguez, Camila Sacristán, Mario Chiong, Miguel Llanos, Alejandra Espinosa, Rodrigo Troncoso. Exercise regulates lipid droplet dynamics in normal and fatty liver. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(12): 158519 doi: 10.1016/j.bbalip.2019.158519
|
| 110 |
Kübra UÇAR, Evrim KAHRAMANOĞLU, Zeynep GÖKTAŞ. Association between caffeine intake and liver biomarkers in non-alcoholic fatty liver disease. Cukurova Medical Journal 2023; 48(1): 177 doi: 10.17826/cumj.1171396
|
| 111 |
Yuling Xing, Tiantian Cheng, Fei Zhou, Huijuan Ma. The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 269 doi: 10.2147/DMSO.S348870
|
| 112 |
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(3): 420 doi: 10.1097/MEG.0000000000001519
|
| 113 |
Ebe D'Adamo, Valeria Castorani, Valerio Nobili. The Liver in Children With Metabolic Syndrome. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00514
|
| 114 |
Sara Della Torre. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells 2021; 10(9): 2502 doi: 10.3390/cells10092502
|
| 115 |
Gh Jeelani Mir, Nissar Ul Ashraf. Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD). The International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906299478240614100954
|
| 116 |
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARα. Biochemical Journal 2019; 476(2): 385 doi: 10.1042/BCJ20180517
|
| 117 |
Nicholas W.S. Chew, Mark D. Muthiah, Arun J. Sanyal. Cardiovascular Endocrinology and Metabolism. 2023; : 137 doi: 10.1016/B978-0-323-99991-5.00003-6
|
| 118 |
Dídac Mauricio, Núria Alonso, Mònica Gratacòs. Chronic Diabetes Complications: The Need to Move beyond Classical Concepts. Trends in Endocrinology & Metabolism 2020; 31(4): 287 doi: 10.1016/j.tem.2020.01.007
|
| 119 |
Chen Chen, Caiyun Zhang, Xuelin Wang, Feijuan Zhang, Ze Zhang, Pengchai Ma, Shuzhi Feng. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. European Journal of Gastroenterology & Hepatology 2020; 32(7): 857 doi: 10.1097/MEG.0000000000001601
|
| 120 |
Ivana Mikolasevic, Sandra Milic, Tajana Filipec‐Kanizaj. Fatty liver allografts are associated with primary graft non‐function and high mortality after transplantation. Liver International 2017; 37(8): 1113 doi: 10.1111/liv.13453
|
| 121 |
Sonja Marinović, Maja Lenartić, Karlo Mladenić, Marko Šestan, Inga Kavazović, Ante Benić, Mia Krapić, Lukas Rindlisbacher, Maja Cokarić Brdovčak, Colin Sparano, Gioana Litscher, Tamara Turk Wensveen, Ivana Mikolašević, Dora Fučkar Čupić, Lidija Bilić-Zulle, Aleksander Steinle, Ari Waisman, Adrian Hayday, Sonia Tugues, Burkhard Becher, Bojan Polić, Felix M. Wensveen. NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis. Science Immunology 2023; 8(87) doi: 10.1126/sciimmunol.add1599
|
| 122 |
Seong-Ah Kim, Sangah Shin. Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study. Journal of Epidemiology and Community Health 2020; 74(12): 1035 doi: 10.1136/jech-2020-214568
|
| 123 |
Polycystic ovary syndrome: approach to correction of metabolic disorders. REPRODUCTIVE ENDOCRINOLOGY 2020; (52): 54 doi: 10.18370/2309-4117.2020.52.54-60
|
| 124 |
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences 2020; 21(24): 9362 doi: 10.3390/ijms21249362
|
| 125 |
Abdulhadi I. Bima, Abdullah S. Mahdi, Fayza F. Al Fayez, Taghreed M. Khawaja, Salwa M. Abo El-Khair, Ayman Z. Elsamanoudy. Cellular Senescence and Vitamin D Deficiency Play a Role in the Pathogenesis of Obesity-Associated Subclinical Atherosclerosis: Study of the Potential Protective Role of Vitamin D Supplementation. Cells 2021; 10(4): 920 doi: 10.3390/cells10040920
|
| 126 |
Honglin Zhou, Cheng Ma, Cheng Wang, Lihong Gong, Yafang Zhang, Yunxia Li. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. European Journal of Pharmacology 2021; 898: 173976 doi: 10.1016/j.ejphar.2021.173976
|
| 127 |
Janusz Strychalski, Andrzej Gugołek, Zofia Antoszkiewicz, Dorota Fopp-Bayat, Edyta Kaczorek-Łukowska, Anna Snarska, Grzegorz Zwierzchowski, Angelika Król-Grzymała, Paulius Matusevičius. The Effect of the BCO2 Genotype on the Expression of Genes Related to Carotenoid, Retinol, and α-Tocopherol Metabolism in Rabbits Fed a Diet with Aztec Marigold Flower Extract. International Journal of Molecular Sciences 2022; 23(18): 10552 doi: 10.3390/ijms231810552
|
| 128 |
Wenbo Dong, Yan Jin, Hongshuo Shi, Xuecheng Zhang, Jinshu Chen, Hongling Jia, Yongchen Zhang. Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease. Medicine 2023; 102(23): e33912 doi: 10.1097/MD.0000000000033912
|
| 129 |
Yujun Li, Ying Chang, Yikai Zhang, Wenling Tu, Fuhang Xu, Liangxiao Zhang, Xiao Wang, Lei Wang. The potential health benefits and mechanisms of sesame lignans in age-related diseases. Food Bioscience 2024; 62: 105360 doi: 10.1016/j.fbio.2024.105360
|
| 130 |
Mi-Young Kim, Sang-Woon Choi. Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?. Applied Sciences 2020; 11(1): 218 doi: 10.3390/app11010218
|
| 131 |
Natalia Zhelezniakova, Iryna Tverezovska. Diagnostic and prognostic value of selenium and Selenoprotein P in patients with comorbid course of nonalcoholic fatty liver disease and arterial hypertension. Medicinski casopis 2022; 56(2): 68 doi: 10.5937/mckg56-36421
|
| 132 |
Robin C. Su, Apurva Lad, Joshua D. Breidenbach, Thomas M. Blomquist, William T. Gunning, Prabhatchandra Dube, Andrew L. Kleinhenz, Deepak Malhotra, Steven T. Haller, David J. Kennedy, Luca Vanella. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLOS ONE 2019; 14(12): e0225604 doi: 10.1371/journal.pone.0225604
|
| 133 |
Ivica Grgurevic, Nermin Salkic, Sanda Mustapic, Tomislav Bokun, Kristian Podrug, Srecko Marusic, Dario Rahelic, Tomas Matic, Viktoria Skurla, Ivana Mikolasevic, Branka Filipović. Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/5582813
|
| 134 |
Cheng-Sheng Yu, Shy-Shin Chang, Chang-Hsien Lin, Yu-Jiun Lin, Jenny L. Wu, Ray-Jade Chen. Identify the Characteristics of Metabolic Syndrome and Non-obese Phenotype: Data Visualization and a Machine Learning Approach. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.626580
|
| 135 |
Janna L. Morrison, Oyekoya T. Ayonrinde, Alison S. Care, Geoffrey D. Clarke, Jack R.T. Darby, Anna L. David, Justin M. Dean, Stuart B. Hooper, Marcus J. Kitchen, Christopher K. Macgowan, Andrew Melbourne, Erin V McGillick, Charles A. McKenzie, Navin Michael, Nuruddin Mohammed, Suresh Anand Sadananthan, Eric Schrauben, Timothy R.H. Regnault, S. Sendhil Velan. Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress. Journal of Developmental Origins of Health and Disease 2021; 12(2): 153 doi: 10.1017/S2040174420000884
|
| 136 |
Mee-Ri Lee, Youn-Hee Lim, Bo-Eun Lee, Yun-Chul Hong. Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study. Environmental Health 2017; 16(1) doi: 10.1186/s12940-017-0228-2
|
| 137 |
Elham Karimi-Sales, Sajad Jeddi, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour. trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. Food & Function 2018; 9(8): 4292 doi: 10.1039/C8FO00923F
|
| 138 |
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno. Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. Biomedicines 2021; 9(11): 1647 doi: 10.3390/biomedicines9111647
|
| 139 |
Mohamed Diwan M. AbdulHameed, Venkat R. Pannala, Anders Wallqvist. Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01007
|
| 140 |
Marion Adam, Hanna Heikelä, Cyril Sobolewski, Dorothea Portius, Jenni Mäki-Jouppila, Arfa Mehmood, Prem Adhikari, Irene Esposito, Laura L. Elo, Fu-Ping Zhang, Suvi T. Ruohonen, Leena Strauss, Michelangelo Foti, Matti Poutanen. Hydroxysteroid (17β) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice. The FASEB Journal 2018; 32(6): 3434 doi: 10.1096/fj.201700914R
|